Your Body's Secret Weapon (Itself)

In 2013, Accelerate Brain Cancer Cure, the Florida Brain Tumor Association and Paul Hale of the Bret Hale Memorial Fund awarded more than $500,000 to Dr. Duane Mitchell at University of Florida to develop the first pediatric brain tumor immunotherapy trial at UF.  The following article by UF Health provides an update on this pioneering research.

It all started with a  book.

While he was in college, Duane A. Mitchell, M.D., Ph.D., read “The Transformed Cell,” a book that truly “transformed” his life.

Written by Steven A. Rosenberg, M.D., Ph.D., chief of surgery at the National Cancer Institute, the book details the years Rosenberg spent developing a treatment for melanoma using a patient’s own immune system, a process known as immunotherapy. Reading about Rosenberg’s work inspired Mitchell’s own interest in immunotherapy.

Now the co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy and director of the UF Brain Tumor Immunotherapy Program, Mitchell’s interest in immunotherapy has blossomed into a full-blown research career. Before coming to UF, Mitchell worked for eight years at Duke University, where he was associate director of the brain tumor immunotherapy program and held multiple positions related to brain tumor research.

Since arriving at UF Health in July 2013, Mitchell and his team have received funds from organizations such as the Department of Defense and Accelerate Brain Cancer Cure to support UF’s first pediatric brain tumor immunotherapy trial.

Click here to read the full article in UF Health.

Share |
July 25, 2014 10:51 AM
Guest blogger Lisa Peabody shares her personal story and her experience as an advocate at the recent Alliance for Childhood Cancer Action Day.
July 3, 2014 11:01 AM
ABC2 helped fund the early-stage research by Dr. Andrew Parsa that is now being developed by Agenus.
June 24, 2014 03:22 PM
Join us for the screening and meet Maria Parker, the inspiring cyclist profiled in the film.  Proceeds benefit 3000 Miles To A Cure in partnership with ABC2.

Join us in our fight for a cure!

Twitter